Finpecia is a brand-name pill that contains finasteride as its active component. It is marketed in a 1 mg tablet formulation and is classified under men’s health medications. In Hong Kong, finasteride-containing products are prescription-only medicines regulated by the Department of Health, which aligns with FDA and EMA standards for safety and efficacy. Finpecia is primarily prescribed to treat male pattern hair loss (androgenetic alopecia) in adult men.
Finasteride belongs to the class of 5-alpha-reductase inhibitors. It blocks the type II isoenzyme responsible for converting testosterone into dihydrotestosterone (DHT), a hormone that shrinks hair follicles on the scalp. By lowering DHT levels in the scalp, finasteride helps to halt further hair thinning and can promote regrowth in affected areas. The drug is absorbed after oral administration, reaches peak plasma concentrations within 2-6 hours, and has a biological half-life of approximately 5-7 days, allowing for once-daily dosing.
Finpecia’s active ingredient, finasteride, has been studied in lower doses for conditions such as:
Disclaimer: Off-label use requires medical supervision and individualized risk assessment.
Absolute contraindications
Known hypersensitivity to finasteride or any tablet excipients.
Women who are pregnant, may become pregnant, or are breastfeeding - exposure can cause birth-related abnormalities of the male fetal genitalia.
Children and adolescents (under 18 years) for hair-loss treatment.
Relative contraindications
Men with severe liver impairment (since metabolism may be reduced).
Patients taking medications that significantly affect hormonal pathways (e.g., anabolic steroids).
If any of these conditions apply, discuss alternatives with a healthcare professional.
These effects are usually mild and often improve with continued therapy. If they persist beyond a few weeks, seek medical advice.
Immediate medical attention is warranted for any severe allergic response or marked mood disturbances.
Finasteride undergoes limited metabolism and has a low potential for pharmacokinetic interactions. Nevertheless:
Patients should provide a complete medication list-including over-the-counter drugs, supplements, and herbal products-to their prescriber.
This article provides educational information about Finpecia and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Yes. Finpecia tablets can be carried in hand luggage, but keep them in the original pharmacy-labeled container to avoid customs confusion. Ensure you have a copy of the prescription in case local authorities request proof of medical need.
Finasteride was once listed as a prohibited substance by certain sports agencies because it can mask steroid use. However, most major organizations, including WADA, have removed it from the banned list. Athletes should still verify the current status with their governing body before competition.
Resume the once-daily regimen on the next day without taking extra tablets to “catch up.” Missing multiple doses may temporarily reduce the drug’s effect on DHT levels, delaying visible hair-regrowth benefits.
Both finasteride and saw-palmetto aim to lower DHT, so combining them may increase the risk of side effects such as sexual dysfunction. Discuss any supplement use with your prescriber to ensure safety.
Finasteride tablets of 1 mg are available as generic products in Hong Kong pharmacies. Generic versions contain the same active ingredient and are therapeutically equivalent when prescribed by a qualified clinician.
Finpecia is contraindicated in women, especially those who are pregnant or may become pregnant, due to the risk of fetal abnormalities. Female hair-loss treatments should be discussed with a dermatologist.
Most men notice a reduction in hair shedding within 2-3 months, with measurable regrowth typically appearing after 6-12 months of continuous use. Patience and adherence to daily dosing are essential for optimal outcomes.
Exposure to high humidity, extreme heat, or direct sunlight can compromise tablet integrity. Store the medication in a cool, dry place and avoid keeping it in a bathroom cabinet where moisture fluctuates.
Finasteride does not have a direct pharmacodynamic interaction with antihypertensive agents. Nonetheless, any new medication should be reviewed for potential additive effects on dizziness or orthostatic hypotension, especially in older adults.
Finasteride primarily affects hair follicles sensitive to DHT, commonly those at the crown and frontal scalp. The occipital region (back of the head) is often genetically protected from DHT-induced miniaturization, so thinning may persist there despite treatment.
